首页> 美国卫生研究院文献>Scientific Reports >Daily high-frequency transcranial random noise stimulation of bilateral temporal cortex in chronic tinnitus – a pilot study
【2h】

Daily high-frequency transcranial random noise stimulation of bilateral temporal cortex in chronic tinnitus – a pilot study

机译:慢性耳鸣每日高频经颅随机噪声刺激双侧颞叶皮质的初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several studies emphasized the potential of single and multiple transcranial random noise stimulation (tRNS) sessions to interfere with auditory cortical activity and to reduce tinnitus loudness. It was the objective of the present study to evaluate the use of high-frequency (hf) tRNS in a one-arm pilot study in patients with chronic tinnitus. Therefore, 30 patients received 10 sessions of high frequency tRNS (100-640 Hz; 2 mA; 20 minutes) over the bilateral temporal cortex. All patients had received rTMS treatment for their tinnitus at least 3 months before tRNS. Primary outcome was treatment response (tinnitus questionnaire reduction of ≥5 points). The trial was registered at clinicaltrials.gov (). Eight patients (27%) responded to tRNS. Exactly the same number of patients had responded before to rTMS, but there were only two “double responders” for both treatments. None of the secondary outcomes (tinnitus numeric rating scales, depressivity, and quality of life) was significant when results were corrected for multiple comparisons. tRNS treatment was accompanied by tolerable side effects but resulted in temporal increases in tinnitus loudness in 20% of the cases (2 drop-outs). Our trial showed that hf-tRNS is feasible for daily treatment in chronic tinnitus. However, summarizing low treatment response, increase of tinnitus loudness in 20% of patients and missing of any significant secondary outcome, the use of hf-tRNS as a general treatment for chronic tinnitus cannot be recommended at this stage. Differences in treatment responders between tRNS and rTMS highlight the need for individualized treatment procedures.
机译:多项研究强调单次和多次经颅随机噪声刺激(tRNS)会议可能会干扰听觉皮层活动并降低耳鸣响度。本研究的目的是评估在慢性耳鸣患者的单臂先导研究中高频(hf)tRNS的使用。因此,有30名患者在双侧颞叶皮层接受了10次高频tRNS治疗(100-640 Hz; 2 mA; 20分钟)。所有患者在tRNS之前至少3个月接受耳鸣的rTMS治疗。主要结果是治疗反应(耳鸣问卷减少≥5分)。该试验已在Clinicaltrials.gov()上注册。 8位患者(27%)对tRNS有反应。在使用rTMS之前,确实有相同数量的患者对rTMS产生了反应,但是两种治疗方法只有两个“双重反应者”。当对结果进行多次比较校正时,次要结果(耳鸣数字评分量表,抑郁和生活质量)均不显着。 tRNS治疗伴随可耐受的副作用,但导致20%的病例耳鸣响度随时间增加(2例退出)。我们的试验表明,hf-tRNS对于慢性耳鸣的日常治疗是可行的。但是,总结出低的治疗反应,20%的患者耳鸣响度增加以及缺少任何重要的继发结局,现阶段不建议使用hf-tRNS作为慢性耳鸣的一般治疗方法。 tRNS和rTMS在治疗反应者方面的差异凸显了对个体化治疗程序的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号